Best NAD+ Supplements in 2026: 7 Ranked by Clinical Evidence

Key Takeaways

NAD+ levels decline with age, a pattern observed across multiple human tissues including skin (Massudi et al., 2012, PLoS ONE), though the magnitude and consistency of this decline in humans remain debated. Two precursors dominate the supplement market: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Both raise blood NAD+ reliably in human trials. NMN converts to NAD+ in one enzymatic step; NR requires two. See what is NMN for the full biochemistry. Neither has proven clinical superiority in outcomes. A 2018 review in Cell Metabolism by Rajman, Chwalek, and Sinclair at Harvard Medical School reviewed the evidence that restoring NAD+ can promote health and extend lifespan in animal models, while emphasizing that the translational potential in humans still requires larger and longer clinical trials. When choosing the best NAD+ supplement, verified purity, realistic dosing, and third-party testing matter more than marketing claims about absorption technology.

What do researchers say about NAD+ supplements?

We looked at what four of the most-cited longevity researchers have said publicly about NAD+ supplementation. Their views range from cautious optimism to outright skepticism about longevity claims. None dismiss NAD+ precursors entirely.

Dr. Peter Attia, MD (Stanford/Johns Hopkins-trained, author of Outlive): Attia has described the NAD+ hype as mostly "noise," stating that the connection to increased longevity is "still unclear." In his own analysis (peterattiamd.com) and on the Huberman Lab podcast, he has argued that the NMN-vs-NR debate is largely a commercial one, since neither precursor has demonstrated a meaningful impact on human lifespan." He does acknowledge that oral NMN and NR are the most effective methods for raising NAD+ levels.

Dr. Andrew Huberman, PhD (Stanford neuroscientist, Huberman Lab): Huberman takes approximately 1–2 g NMN sublingually each morning. On the Joe Rogan podcast, he reported "a definite, subjective feeling of an increase in energy." He has been explicit that he takes NMN and NR for energy and recovery, not for longevity: "There are some animal data suggesting that increasing NAD+ can increase lifespan. But frankly, that is not why I take NR and NMN."

Dr. Eric Verdin, MD (CEO, Buck Institute for Research on Aging): On The Peter Attia Drive, Verdin stated it is "relatively safe to take 250 mg each of both NMN and NR." He also said that IV NAD+ is "not worth the money" and warned against giving up on the NAD+ field just because it has been commercialized.

Dr. David Sinclair, PhD (Harvard Medical School): Sinclair has publicly disclosed taking 1 g NMN with 1 g resveratrol daily. His 2018 Cell Metabolism review argued that NAD-boosting molecules hold promise for increasing resilience to multiple age-related diseases, while acknowledging the human evidence was still preliminary. He remains the most bullish major researcher on NAD+ supplementation (see our honest review of Sinclair's stack). He is also the most commercially involved, which readers should weigh accordingly.

Why does NAD+ decline with age?

NAD+ levels decline with age in many tissues, though the exact magnitude in humans is debated and not uniform across tissue types. The decline is driven primarily by an enzyme called CD38, which consumes NAD+ as part of the inflammatory response. Chronic, low-grade inflammation increases with age.

Dr. Eric Verdin at the Buck Institute has studied CD38 extensively. His team found that if you block CD38 in mice, NAD+ levels do not decline with age at all. CD38 does not only consume NAD+. It also cleaves NMN, the precursor you might be supplementing with. This means inflammation is simultaneously depleting your NAD+ and destroying the molecule you are taking to replace it. The practical implication: NAD+ supplementation may be more effective when combined with anti-inflammatory strategies (exercise, adequate sleep, omega-3 intake) than in isolation.

Other factors contributing to age-related NAD+ decline include decreased activity of NAMPT (the rate-limiting enzyme in NAD+ salvage synthesis), increased DNA damage activating PARP enzymes that consume NAD+ for repair, and reduced dietary intake of NAD+ precursors like tryptophan and niacin. The decline is not uniform across tissues. Attia notes that skin shows the most dramatic reduction, which may explain why some of the strongest evidence for NR supplementation benefits appears in dermatological studies.

This multi-factor decline is why no single supplement fully reverses it. Raising NAD+ with NMN or NR addresses the supply side. But if CD38 activity remains elevated due to chronic inflammation, you are pouring water into a leaking bucket. The supplements in this comparison can increase the flow. See our NAD+ supplement guide for a deeper look at the biology. Fixing the leak requires lifestyle changes that no capsule replaces.

What do human trials actually show?

Both NMN and NR reliably raise blood NAD+ in humans. The more important question, whether that translates into meaningful health outcomes, has partial answers at best.

NR trial evidence: Martens et al. (2018, Nature Communications) remains the landmark NR study. Healthy older adults (60–80 years) took 500 mg NR twice daily for 6 weeks. NAD+ rose by 60%. There was a trend toward lower blood pressure and reduced aortic stiffness, but neither reached statistical significance in this small sample. Dollerup et al. (2018) tested NR in obese, insulin-resistant men for 12 weeks. NAD+ increased. No significant improvements in insulin sensitivity, body composition, or exercise capacity were observed. Elysium's own Basis trial (Dellinger et al., 2017) showed 40% NAD+ elevation at 4 weeks with NR + pterostilbene, sustained at 8 weeks, but measured no functional outcomes beyond the biomarker.

NMN trial evidence: Yi et al. (2023, GeroScience) tested 300, 600, and 900 mg/day NMN in 80 healthy middle-aged adults. NAD+ increased dose-dependently. Six-minute walking distance improved at 600 and 900 mg, one of the few functional outcomes in the NMN literature. Yoshino et al. (2021, Science) gave 250 mg NMN to prediabetic postmenopausal women for 10 weeks. Muscle insulin sensitivity improved, but blood glucose, body weight, and blood pressure did not change. A 2024 systematic review and meta-analysis of 12 RCTs (513 participants) confirmed that NMN significantly raises blood NAD+ levels, but found that most clinically relevant metabolic outcomes did not differ significantly from placebo, cautioning that the benefits of NMN may be overstated in the field.

The head-to-head: Christen et al. (2026, Nature Metabolism) ran the first direct NMN-vs-NR crossover trial in 65 healthy adults. Both precursors raised circulatory NAD+ by comparable amounts at 1,000 mg/day over 14 days. This trial effectively ended the "which precursor is better" debate. See our full NMN vs NAD comparison for the biochemistry, at least for the basic endpoint of raising blood NAD+.

What is still missing: No published RCT has shown that NMN or NR extends human lifespan. No trial longer than 12 months exists for either precursor. The Interventions Testing Program (ITP), the gold standard for longevity molecule testing in mice, found that NR failed to extend lifespan even at robust doses. Attia considers this a significant negative signal. The disconnect between mechanistic promise and outcome data is the central tension in the NAD+ supplement field, and any product claiming to reverse aging is ahead of what the evidence supports.

What about NAD+ patches?

NAD+ patches are a newer delivery format claiming transdermal absorption. The evidence for this route is extremely limited. No published human trial has validated that NAD+ or its precursors can cross the skin barrier in meaningful quantities.

Brands like Ionlayer and PatchMD market NAD+ patches as an alternative to capsules, claiming sustained release and improved bioavailability. The theoretical appeal is real: bypassing the GI tract avoids first-pass metabolism and CD38-mediated degradation in the gut. But the practical problem is that NAD+ is a large, charged molecule (~663 Da) that does not passively penetrate skin. Transdermal delivery of molecules this size typically requires iontophoresis or microneedle technology, neither of which current consumer patches use.

Some patches contain NMN or NR instead of NAD+ itself, which are smaller molecules. Even so, no published data confirms that these precursors reach the bloodstream via a dermal patch at concentrations comparable to oral supplementation. Anecdotal reports on Reddit and longevity forums are mixed. Some users report subjective effects, others report nothing. Without pharmacokinetic validation, patches remain speculative. If you want to try an alternative delivery format, Our NAD+ injections guide covers alternative delivery routes in detail. Renue By Science's sublingual NMN has a somewhat stronger (though still limited) theoretical basis than transdermal patches.

How to build an NAD+ stack without overdoing it

Start with one precursor at a clinical dose. Add complementary molecules only after establishing your baseline response over 4–8 weeks. Most people do not need a complex stack.

Tier 1 — The foundation (pick one): NMN 500 mg/day OR NR 300–500 mg/day. This is the only evidence-backed starting point. Take in the morning. Assess subjective response (energy, recovery, sleep quality) for 4–8 weeks before adding anything.

Tier 2 — Complementary, if desired: Resveratrol or pterostilbene (500–1,000 mg) for sirtuin activation. TMG/betaine (500–1,000 mg) to support the methylation demand that NAD+ synthesis creates. These are the most commonly discussed stack additions in the longevity community, and the Sinclair and Elysium protocols both incorporate a polyphenol alongside the NAD+ precursor. See NMN and resveratrol: Sinclair's stack reviewed.

Tier 3 — Speculative: Apigenin (50 mg, a CD38 inhibitor). Fisetin or quercetin (senolytic agents). These have mechanistic rationale but minimal human evidence as NAD+ stack components.

What not to stack: NMN and NR together. Both converge on the same pathway, and no data supports combining them at sub-doses over using one at a full dose. Niacin (nicotinic acid) alongside NMN/NR. The flushing and different metabolic pathway add side effects without clear synergy.

The most important "stack" addition is not a supplement. It is exercise. A single bout of aerobic exercise raises skeletal muscle NAD+ by 20–50%. Consistent exercise upregulates NAMPT, the rate-limiting enzyme in NAD+ synthesis. No supplement matches this effect size, and combining exercise with NAD+ precursor supplementation likely produces better results than either alone, though this specific combination has not been tested in a controlled trial.

We Sell One of These. Let's Get That Out of the Way.

YourHealthier sells an NMN supplement. It appears in this comparison alongside six competitors. It scored 60/100, not first. Tru Niagen's NR has more clinical data behind it. ProHealth's Uthever® NMN has better supply-chain traceability. We include our product because leaving it out would be stranger than including it, but we applied the same scoring methodology to ourselves. Where a competitor outperforms us, we say so.

What's the honest NAD+ supplement ranking?

By evidence, Tru Niagen (NR) leads on clinical trial volume. ProHealth leads for NMN with Uthever® traceability. The 2026 Christen trial settled the NMN-vs-NR debate: they raise NAD+ equivalently. So pick based on testing, dose, and cost, not precursor marketing.

How do the top NAD+ supplements compare?

Does Tru Niagen deserve the top spot?

Yes, on evidence alone. ChromaDex invested in clinical research before anyone else. 40+ published studies on the Niagen ingredient, including Martens et al. (2018) in Nature Communications showing 60% NAD+ elevation in healthy older adults. NSF certified. 300 mg per capsule at ~$1.50/day.

The trade-off: 300 mg is the lower end of studied NR doses. Some trials used 600–1,000 mg. And NR is not inherently superior to NMN. The Christen 2026 trial showed equivalent NAD+ elevation from both. You're paying for ChromaDex's research track record, not a fundamentally better molecule. If that matters to you, Tru Niagen is the obvious pick. If cost-per-milligram matters more, Life Extension uses the same Niagen ingredient for ~30% less.

Is Elysium Basis worth the premium?

Basis combines 250 mg NR with 50 mg pterostilbene, a resveratrol analog that activates SIRT1. Co-founded by MIT professor Leonard Guarente. NSF Certified for Sport. Published brand-specific clinical trial showing 40% NAD+ elevation at 4 weeks (Dellinger et al., 2017).

At ~$2.00/day, it's the most expensive product here. The pterostilbene addition is scientifically interesting but the combination hasn't been tested against NR alone in a head-to-head trial. 250 mg NR is a low dose. You're paying for the combination concept and the MIT pedigree. That might be worth it if you want a single-capsule NR + polyphenol stack. It's not worth it if you're just looking for the most NR per dollar.

ProHealth NMN Pro: the longevity community's default

ProHealth uses Uthever® NMN, a branded, audited ingredient from EffePharm (Shanghai) with published stability data. 500 mg or 1,000 mg options. Third-party COAs available. Supplement company since 1988.

If you ask on Reddit's r/NMN or any longevity forum which NMN to buy, ProHealth comes up constantly. The Uthever® branding adds a layer of supply-chain traceability that independently-sourced NMN (including ours) doesn't match the same way. The 1,000 mg option at ~$1.50/day is the most cost-effective way to run a high-dose NMN protocol. Downside: website feels dated, some formulations add extras you may not want.

Life Extension NAD+ Cell Regenerator: same Niagen, less money

Same ChromaDex Niagen ingredient as Tru Niagen. Same 300 mg dose. ~30–40% cheaper. 40+ year supplement company. ConsumerLab verified.

The clinical data doesn't care whose label is on the bottle. If the Niagen research convinced you NR is the right path, Life Extension is the no-brainer budget option. They also offer a combined version with trans-resveratrol. The only reasons to choose Tru Niagen over Life Extension are NSF certification (which Life Extension doesn't carry for this product) and brand preference.

YourHealthier NMN: what we built and where it falls short

500 mg β-NMN per capsule, single ingredient, third-party tested for identity, purity, and potency, with a published COA. $1.67/day ($49.95 for 30 capsules). We formulated it to match the dose used in Yi et al. (2023) and other recent RCTs.

What we prioritized: purity you can verify. Our third-party testing confirms the capsule contains actual β-NMN, the bioavailable isomer, not NR or plain nicotinamide relabeled as NMN, which independent testing has repeatedly caught cheaper products doing. It is a single active ingredient: no fillers, no proprietary blends, no added resveratrol or quercetin padding out the label. If you want to know exactly what you are taking and at what dose, that is the point of this formulation. It is made in a GMP-certified US facility in vegan HPMC capsules, and you can run it at 500 mg (one capsule) for maintenance or 1,000 mg (two capsules) to match the higher clinical-trial protocols. Where it falls short, honestly: no Uthever® certification, so we do not carry that specific branded-ingredient audit trail, ProHealth does. Smaller brand with fewer customer reviews than ProHealth or Renue. Standard capsule, not sublingual or liposomal, so if delivery-technology innovation is your priority, Renue has more to offer. On price, at $1.67/day we sit mid-pack, not at the bottom: Double Wood is cheaper per milligram. What you are paying for with us is verified β-NMN identity and a clean single-ingredient label, not the lowest sticker price. That is a narrow lane, but it is the lane we built for.

Renue By Science and Double Wood: liposomal vs budget

Renue wraps NMN in liposomes for theoretically better absorption (~$1.33/day, 250 mg). Double Wood delivers 500 mg standard NMN at the lowest cost (~$0.47/day).

Renue is for biohackers. The liposomal delivery concept is pharmacologically sound, but no published human trial has compared liposomal NMN absorption to standard capsules. You're paying for theoretical advantage. They also offer sublingual and nasal formats with even less absorption data. If you want the most scientifically conservative choice, standard capsules matching published trial protocols are safer.

Double Wood is the entry point. 500 mg, third-party tested, cheapest per serving by far. Less transparent on sourcing than ProHealth. Worth it if cost is the barrier between you and trying NMN. Start here, upgrade to a more audited brand if NMN becomes part of your long-term stack.

What's new in NAD+ supplement research (2025–2026)?

The field has moved faster in the last 18 months than in the previous five years. Three developments matter most for supplement buyers: the first NMN-vs-NR head-to-head, a comprehensive systematic review, and the NIA-funded tissue-level validation study.

Christen et al. (2026, Nature Metabolism): The first randomized trial directly comparing NMN and NR in the same participants. 65 healthy adults took 1,000 mg of NMN, NR, or nicotinamide for 14 days each in a crossover design. Result: NMN and NR raised circulatory NAD+ by comparable amounts. Nicotinamide (plain vitamin B3) did not. The trial also found that NR and NMN improved gut microbial metabolism in ex vivo fecal analyses, a novel finding suggesting NAD+ precursors may have prebiotic effects. This trial ended the "which precursor is better" marketing war with a clear answer: they are equivalent for NAD+ elevation.

Vinten et al. (2025, Nature Metabolism): A systematic review from Amsterdam UMC and EPFL covering all published human NAD+ precursor trials. Their conclusion: "NAD+ precursor supplementation reliably increases circulating NAD+ metabolites in humans, but that human clinical trials have so far shown limited efficacy." It is among the most authoritative recent summaries of where the evidence stands: the biomarker effect (raising NAD+) is confirmed, but human health outcomes remain unproven.

NIA/University of Pennsylvania (2026, ongoing): A National Institute on Aging-funded study using magnetic resonance spectroscopy (MRS) to measure NAD+ levels in both blood AND brain tissue before and after NR supplementation. This is the first study designed to answer whether oral NAD+ precursors actually reach the brain. This is a critical question for the cognitive and neuroprotective claims that dominate NAD+ supplement marketing. Early-stage results from a related Christen study found that NR elevated brain NAD+ by 29–39% after 4 weeks, though this was in a small open-label design.

Reyna et al. (2026, Frontiers in Aging): A retrospective tolerability study comparing IV NAD+ infusion to oral NR in a clinical setting. Both raised NAD+, but IV administration caused significantly more side effects (nausea, cramping, chest pressure). This adds to the evidence that oral precursors are the more practical delivery route for most people.

The direction is clear: NAD+ precursor research is shifting from "does it raise NAD+" (yes, established) to "does raising NAD+ produce clinically meaningful health outcomes" (unknown, actively being studied). The next 2–3 years of trial results will determine whether NAD+ supplements graduate from promising biomarker intervention to proven health intervention.

NMN vs NR: what the 2026 trial settled

The Christen 2026 crossover trial, the first direct head-to-head, found NMN and NR raise NAD+ by equivalent amounts in healthy adults. The precursor debate is over. Both work. Pick based on product quality, not molecule marketing.

NR entered the market first. ChromaDex invested heavily in clinical research, giving Tru Niagen a meaningful evidence lead (40+ studies vs 12+ for NMN). But NMN has caught up fast. A 2024 meta-analysis of 513 participants confirmed NMN raises NAD+ with no serious adverse events up to 1,250 mg/day. Yi et al. (2023) showed dose-dependent improvements in walking endurance. Yoshino (2021) found improved insulin sensitivity in prediabetic women. The evidence gap is narrowing, and the head-to-head result says the molecules are interchangeable for the basic task of raising NAD+.

A 2025 systematic review in Nature Metabolism from Amsterdam UMC and EPFL concluded that while preclinical studies support NAD+ precursor supplementation as a promising strategy, human clinical trials have so far shown limited efficacy, and evidence for an age-related NAD+ decline in humans has been observed consistently in only a limited number of studies. The National Institute on Aging (NIA) is currently funding a NAD+ validation study with the University of Pennsylvania, using MRS imaging to correlate blood and tissue NAD+ levels after NR supplementation. This is the kind of methodological work needed to move the field forward.

What remains unresolved: long-term health outcomes. No published RCT has demonstrated that NMN or NR extends human lifespan. The anti-aging claims are extrapolated from animal models and biomarker data. Raising NAD+ is confirmed. What that means for aging is not.

What We Hear From Customers

The most common report: "I didn't feel anything for 3 weeks, then noticed I was recovering faster from workouts." The second most common: "No difference at all." Both are honest. NAD+ supplementation is subtle and cumulative, not acute.

Nobody has told us NMN reversed their aging. What some people report, consistently enough to note, is modest improvements in energy stability, exercise recovery, and sleep quality after 4–8 weeks. Others notice nothing. Individual variation in NAD+ metabolism, baseline status, and expectations makes this impossible to predict. A supplement that works by d = 0.2–0.3 feels like nothing to some people and meaningful to others.

The third most common report, and the most interesting: people who stop taking NMN for a few weeks and then notice a difference in its absence. Several customers have told us they didn't believe NMN was doing anything until they ran out, didn't reorder for a month, and then noticed their afternoon energy dip returning or their post-workout soreness increasing. We cover this pattern in detail in why people stop taking NMN. This is consistent with how a subtle, cumulative intervention would feel: invisible while present, noticeable only when withdrawn. It's also consistent with placebo, and we want to be honest about that ambiguity.

What nobody has reported: looking younger, reversing gray hair, dramatic cognitive improvement, or anything resembling the marketing claims on some NAD+ supplement websites. If your expectations are set by Instagram longevity influencers, you will likely be disappointed. If your expectations are "a modest boost in daily energy consistency," that's the range where our customers report satisfaction.

Do sleep and exercise raise NAD+ more than supplements?

Yes. A single session of aerobic exercise raises skeletal muscle NAD+ by 20–50%. Consistent exercise upregulates NAMPT, the rate-limiting enzyme in NAD+ salvage synthesis. Sleep deprivation depletes NAD+ through increased PARP activation from accumulated DNA damage. No supplement matches the effect size of getting these two right.

This is not anti-supplement rhetoric. It is context. If you exercise regularly, sleep 7–9 hours, manage inflammation, and limit alcohol, then supplementation makes sense as an addition to a strong foundation. If you are sedentary, sleep-deprived, and chronically inflamed, a $50/month NAD+ capsule is addressing a symptom while ignoring the cause.

The longevity researchers who take NAD+ precursors (Huberman, Sinclair, Verdin) all exercise intensely and prioritize sleep. They are supplementing on top of a foundation, not instead of one. The Tier 0 in our ranking (exercise, sleep, no alcohol) is not a joke. It is the actual evidence hierarchy.

How to dose NAD+ supplements

NMN: 250–1,250 mg/day based on human trials. Most common effective dose: 500–600 mg/day. Start low, assess over 4–8 weeks. See NMN dosage guide for trial-by-trial dose data.

NR: 300–1,000 mg/day. Tru Niagen recommends 300 mg. Martens (2018) used 500 mg twice daily.

Timing: Morning, based on circadian NAD+ cycling. No RCT has directly compared morning versus evening dosing for outcomes. See best time to take NMN.

Storage: NMN degrades in heat and moisture. Store in a cool, dry place and consider refrigeration. NR (Niagen) is more stable at room temperature.

Who should be cautious

Active or past cancer. NAD+ fuels cell proliferation. No human evidence links NMN/NR to cancer promotion, but the theoretical concern is unresolved. Discuss with your oncologist.

NMN's U.S. regulatory status. In late 2022, the FDA concluded that NMN is excluded from the legal definition of a dietary supplement because it was authorized for investigation as a new drug. As a result, NMN's status as a supplement ingredient is unsettled, and some retailers have delisted it, while NR (Niagen) has FDA GRAS status and remains freely sold. This is a regulatory classification, not a safety finding.

Pregnancy or breastfeeding. No safety data for either precursor.

Blood sugar medication. NMN improved insulin sensitivity in one trial, so monitor glucose if on metformin, sulfonylureas, or insulin.

Immunosuppression. NAD+ modulates immune function through sirtuins. No drug interaction data.

Young, healthy adults under 30. NAD+ levels have not significantly declined at this age. The cost-benefit calculation is different for a 25-year-old with normal NAD+ metabolism than for a 55-year-old with measurably depleted levels. Exercise, sleep optimization, and dietary adequacy are higher-priority interventions at younger ages.

People taking niacin or B-complex supplements. High-dose niacin (nicotinic acid) shares metabolic pathways with NMN and NR. Combining them can lead to excessive NAD+ precursor loading, flushing, and GI discomfort. If you are already taking a B-complex or standalone niacin supplement, account for the niacin contribution before adding NMN or NR.

Frequently Asked Questions

Related Reading

• NAD+ Supplements: Types, Evidence & How to Choose (2026)
• NMN vs NAD: What's the Difference?
• NMN vs NR: Which NAD+ Precursor Is Better?
• 7 Best NMN Supplements in 2026
• NMN and Resveratrol: Sinclair's Stack Reviewed
• NMN Dosage: 250mg vs 600mg vs 1000mg
• NMN Side Effects: What Clinical Trials Report
• NMN Before and After: Real Results
• Best Time to Take NMN: Morning or Night?
• Why People Stop Taking NMN
• NAD+ IV Therapy: How It Works & Evidence
• NAD+ Injections: Benefits, Side Effects & Cost
• What Is NMN? Benefits & Aging Research
• Longevity Supplements

Related Research

• PubMed: 22848760 — NAD+ decline with age
• PubMed: 29599478 — NR raises NAD+ in older adults
• PubMed: 33888596 — NMN improves insulin sensitivity
• PubMed: 36482258 — NMN dose-dependent efficacy trial
• PubMed: 41540253 — NMN vs NR head-to-head
• PubMed: 39116016 — NMN 513-participant meta-analysis
• PubMed: 41083806 — NAD+ precursor systematic review
• PubMed: 29514064 — NAD+ therapeutic potential review
• ClinicalTrials.gov: NCT07416786 — NIA/UPenn NAD+ validation

Our methodology and disclosure

How we built this comparison: We purchased or requested samples from all seven brands listed. Pricing was verified from each brand's official website and Amazon in July 2026. COA availability was confirmed by checking each brand's website and contacting customer support where necessary. Clinical evidence was sourced from PubMed, ClinicalTrials.gov, and the ChromaDex clinical library. No brand paid for inclusion or placement.

Scoring methodology: Each product was scored on five criteria: purity verification (30%), clinical evidence for the active ingredient (25%), dose alignment with published trials (20%), cost per day (15%), and formulation transparency (10%). Scores were normalized to 100. Tru Niagen scored highest (90) due to unmatched clinical trial volume and NSF certification. Our own product scored 60, mid-range, reflecting a strong clinical dose and clean formulation but weaker brand recognition and supply-chain traceability compared to Uthever® products, and mid-pack pricing rather than a cost advantage.

Conflict of interest: YourHealthier NMN is our product. We earn revenue from its sale. We applied identical evaluation criteria to our product and every competitor. Where a competitor outperforms us, we say so explicitly. Tru Niagen has more evidence, ProHealth has better supply-chain traceability, Double Wood is cheaper. Readers should weigh our self-inclusion accordingly.

What we are not: This article is not medical advice. NAD+ supplements are not FDA-approved to treat, cure, or prevent any disease. Consult a healthcare provider before starting any supplement, especially with existing conditions or medications.

Last updated: August 2026. Pricing and product availability subject to change.

References

Sources verified: All PubMed citations and external references in this article were last verified on August 2026.

Disclosure: YourHealthier manufactures and sells the NMN supplement discussed in this article. All health claims are based on published peer-reviewed research cited above. We earn revenue from product sales linked in this article. See our Editorial Policy.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.

Lab Results · Our Science · Editorial Policy

Best NAD+ Supplements 2026

Metric	Value
NR clinical trials	40+ (Niagen)
NMN meta-analysis	513 participants
Head-to-head result	equivalent NAD+ rise
Cost range (per day)	$0.47 - $2.00

Chart: Best NAD+ Supplements 2026. NR clinical trials: 40+ (Niagen); NMN meta-analysis: 513 participants; Head-to-head result: equivalent NAD+ rise; Cost range: $0.47-$2.00/day. Source: Christen 2026, Yi 2023, ChromaDex.